+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07482917

Optimizing Diagnostic Pathways to Reduce Time to Diagnosis in Suspected Interstitial Lung Disease A Randomized Trial Comparing Standard and Coordinated Diagnostic Circuits

Led by Hospital de Granollers · Updated on 2026-10-21

92

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the impact of a coordinated diagnostic pathway compared to standard care for patients suspected of having interstitial lung disease ILD. This study aims to reduce delays and burdens caused by fragmented diagnostic workflows by organizing core diagnostic tests into a more efficient and structured process. The trial is a prospective, randomized, open-label study endorsed by a patient association to ensure a patient-centered approach. Participants are assigned to either the standard diagnostic pathway, where tests like high-resolution chest CT, pulmonary function tests, and laboratory panels are scheduled independently, or to an optimized circuit where these procedures are bundled and scheduled within a compressed timeframe, usually one or two visits. Additional assessments such as bronchoscopy or specialist consultations are included when clinically necessary. Both pathways complete all necessary evaluations without changing clinical content or prioritization. Throughout the study, participants undergo assessments including lung function tests, imaging, laboratory panels, and questionnaires addressing quality of life, anxiety, depression, social support, frailty, and caregiver burden if applicable. The main measure is the time from randomization to when the patient is informed of the final diagnosis. Secondary outcomes include time to multidisciplinary diagnosis, treatment initiation, socioeconomic costs, environmental impact, and patient and caregiver experiences. The study may last up to 18 months per participant, with ongoing monitoring of multiple health and social measures.

CONDITIONS

Brief Title

Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here